SCHEMBL14637359

SCHEMBL14637359

CC(=O)NC(CCCCNC(=O)OC(C)(C)C)C(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.56
CA2 P00918 3/20 0.56
MAP2K1 Q02750 1/20 0.55
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
ALDH1A1 P00352 1/20 0.45
SIRT5 Q9NXA8 1/20 0.43
CYP1A1 P04798 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP2C19 P33261 1/20 0.42
CYP3A43 Q9HB55 1/20 0.42
AR P10275 1/20 0.42
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504063 0.94 MAP2K1 (0.55) CA1CA2MAP2K1CA12CA9
SCHEMBL3504066 0.94 MAP2K1 (0.55) CA1CA2MAP2K1CA12CA9
SCHEMBL3204645 0.83 CA1 (0.61) CA1CA2CA12CA9ALDH1A1
SCHEMBL29550379 0.83 CA1 (0.61) CA1CA2CA12CA9ALDH1A1
Bromide SCHEMBL7547474 0.81 MAP1LC3B (0.46) CA1MAP2K1CA12CA9ALDH1A1
SCHEMBL30453914 0.81 CA1 (0.58) CA1CA2CA12CA9ALDH1A1
SCHEMBL29396685 0.81 CA1 (0.58) CA1CA2CA12CA9ALDH1A1
SCHEMBL12841581 0.79 CA9 (0.50) CA1CA2MAP2K1CA12CA9
SCHEMBL16383357 0.77 CA1 (0.63) CA1CA2CA12CA9ALDH1A1
SCHEMBL29845374 0.77 MAP2K1 (0.42) CA1MAP2K1CA12CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2734500-A2 HISTONE DEACETYLASE 6 SELECTIVE INHIBITORS FOR THE TREATMENT OF BONE DISEASE The General Hospital Corporation (US) 2014-05-28 EP disclosed
WO-2013013113-A2 HISTONE DEACETYLASE 6 SELECTIVE INHIBITORS FOR THE TREATMENT OF BONE DISEASE THE GENERAL HOSPITAL CORPORATION (US) 2013-01-24 WO disclosed